TITLE

Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction

AUTHOR(S)
Bogaty, Peter; Buller, Christopher E.; Dorian, Paul; O'Neill, Blair J.; Armstrong, Paul W.
PUB. DATE
October 2004
SOURCE
CMAJ: Canadian Medical Association Journal;10/26/2004, Vol. 171 Issue 9, p1039
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the application of the guidelines of the American Heart Association on the selection of patients for reperfusion after acute St-segment elevation myocardial infarction (STEMI). Diagnosis for a female patient experiencing jaw discomfort accompanied by diaphoresis and nausea; Factors to be considered in performing reperfusion in STEMI; Reasons for the selection of immediate on-site fibrinolysis for patients with acute myocardial infarction.
ACCESSION #
14736479

 

Related Articles

  • STREAM and FAST-MI–Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era. ElGuindy, Ahmed M. // Global Cardiology Science & Practice;2014, Vol. 2014 Issue 2, p1 

    Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial6 and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)7 are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive...

  • Contemporary Therapy of Acute ST-Elevation Myocardial Infarction. Armstrong, Paul W. // Texas Heart Institute Journal;2009, Vol. 36 Issue 4, p273 

    The article focuses on contemporary therapy of acute ST-elevation myocardial infarction (STEMI). It is said that STEMI serves a key role in the development of more broadly applicable diagnostic and treatment methods. It adds that the choice of reperfusion therapy is optimized based on the...

  • Management of microvascular dysfunction and reperfusion injury. Prasad, A.; Gersh, B. J. // Heart;Dec2005, Vol. 91 Issue 12, p1530 

    The article presents a discussion on the management of microvascular dysfunction and reperfusion injury. Myocardial contrast echo-cardiography has been available for a many years for the assessment of myocardial perfusion, and the recent availability of intravenous contrast agents has made it...

  • Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction. Stone, Gregg W.; Grines, Cindy L.; Cox, David A.; Garcia, Eulogio; Tcheng, James E.; Griffin, John J.; Guagliumi, Giulio; Stuckey, Thomas; Turco, Mark; Carroll, John D.; Rutherford, Barry D.; Lansky, Alexandra J. // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p957 

    Background: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction reduces the rates of death, reinfarction, and stroke, but recurrent ischemia, restenosis, and reocclusion of the infarct-related artery remain...

  • Cardiovascular disease: MYDGF promotes heart repair after myocardial infarction. Cully, Megan // Nature Reviews Drug Discovery;Mar2015, Vol. 14 Issue 3, p164 

    The article reports on the results of a study published in the "Nature Medicine" journal which showed the role of myeloid-derived growth factor (MYDGF) in promoting heart repair. The study used a mouse model that simulates reperfusion therapy after myocardial infarction (MI) to explore the...

  • Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis. Asseburg, Christian; Vergel, Yolanda Bravo; Palmer, Stephen; Fenwick, Elisabeth; de Belder, Mark; Abrams, Keith R.; Sculpher, Mark // Heart;Oct2007, Vol. 93 Issue 10, p1244 

    Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis alter an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered. Objective: To extend earlier meta-analyses by considering 1- and 6-month outcome data for...

  • Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Sörensson, Peder; Saleh, Nawzad; Bouvier, Frederic; Böhm, Felix; Settergren, Magnus; Caidahl, Kenneth; Tornvall, Per; Arheden, Håkan; Rydèc)n, Lars; Pernow, John // Heart;Nov2010, Vol. 96 Issue 21, p1710 

    Background Small studies suggest that postconditioning reperfusion interrupted by brief repetitive cycles of reocclusions, may protect the myocardium in the clinical setting. Objective To test the hypothesis that postconditioning limits infarct size in relation to the area at risk in patients...

  • A Review of Cardiogenic Shock in Acute Myocardial Infarction. Khalid, L.; Dhakam, S. H. // Current Cardiology Reviews;2008, Vol. 4 Issue 1, p34 

    Cardiogenic shock continues to be the most common cause of death in patients hospitalized with acute myocardial infarction. It has also been frequently associated with ST-segment elevation myocardial infarction (STEMI) and patients with co-morbidities. Cardiogenic shock presents with low...

  • Ex Vivo and In Vivo Approaches to Study Mechanisms of Cardioprotection Targeting Ischemia/Reperfusion (I/R) Injury: Useful Techniques for Cardiovascular Drug Discovery. Vidavalur, Ramesh; Swarnakar, Snehasikta; Thirunavukkarasu, Mahesh; Samuel, Samson Mathews; Maulik, Nilanjana // Current Drug Discovery Technologies;Dec2008, Vol. 5 Issue 4, p269 

    The last few decades have seen significant advancement in the therapy of Ischemic Heart Diseases (IHD). This is a direct outcome of the increasing knowledge of the molecular mechanisms involved during an ischemic insult of the myocardium. Even then there is still a major unmet need for better...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics